VIA Pharmaceuticals, Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease. The Company is building a pipeline of small molecule drugs that intervene directly in the chronic inflammation underlying atherosclerosis.
Quote | Via Pharmaceuticals Inc (OTCMKTS:VIAP)
Last: | $1e-06 |
---|---|
Change Percent: | 0.0% |
Open: | $1e-06 |
Close: | $1e-06 |
High: | $1e-06 |
Low: | $1e-06 |
Volume: | 700 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Via Pharmaceuticals Inc (OTCMKTS:VIAP)
2024-04-18 08:05:05 ET More on VIA Pharmaceuticals, Inc. Financial information for VIA Pharmaceuticals, Inc. Read the full article on Seeking Alpha For further details see: VIA Pharmaceuticals, Inc. declares $0.7605 dividend
Message Board Posts | Via Pharmaceuticals Inc (OTCMKTS:VIAP)
Subject | By | Source | When |
---|---|---|---|
07/26/2021 08:00:00 $VIAP | harr449 | investorshub | 07/26/2021 1:15:51 PM |
VIAP SEC Suspension "due to a lack of | Renee | investorshub | 07/12/2021 2:19:53 PM |
$VIAP Volume | CrownCannabis | investorshub | 09/13/2019 6:53:33 PM |
Emylers: VIAP Financials 07/16/2014 01:55:19 VIA Pharmaceuticals, Inc. Period Ending Dec 31, 2010 To | Emylers | investorshangout | 07/16/2014 6:55:16 AM |
My wife is still holding in her | PsD | investorshub | 03/14/2014 4:21:18 PM |